Manuals & Guidelines
Lebanese Guidelines For Erythropoiesis-Stimulating Agents (ESAs) Approval in Non-Dialysis Chronic Kidney Disease (ND-CKD) Patients aT the MOPH
Author: MOPH
Source: MOPH
Source: MOPH
1-ESA initiation
- Address iron deficiency before ESA therapy initiation (iron deficiency defined as ferritin<100 ng/ml and/or transferrin saturation (TSAT)<20%).
- ESA requisition forms that lack ferritin and TSAT values will be returned.
- If Hb ≥ 10 g/dl, ESA will be approved only if patient symptomatic with a ferritin >100 ng/ml and TSAT >20%, otherwise rejected.
- If Hb 9-10 g/dl, ESA will be approved if ferritin>100 ng/ml and TSAT >20%, otherwise rejected.
- If Hb<9 g/dl and ferritin<100 ng/ml and/or TSAT<20%, ESA will be approved for one month and renewed only if ferritin>100 ng/ml and TSAT>20%.
- If Hb< 9g/dl and ferritin>100 ng/ml and TSAT>20%, ESA will be approved...
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
